Heidelberg Pharma AG (HPHA)

BRIEF

published on 11/06/2024 at 10:07, 1 month 15 days ago

Heidelberg Pharma dévoile des données prometteuses sur le HDP-101 à l'ASH 2024

Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques Technologie ADC
BRIEF

published on 11/06/2024 at 10:07, 1 month 15 days ago

Heidelberg Pharma Reveals Promising Data on HDP-101 at ASH 2024

Clinical Data Heidelberg Pharma HDP-101 ADC Technology Multiple Myeloma
PRESS RELEASE

published on 11/06/2024 at 10:02, 1 month 15 days ago

Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
Heidelberg Pharma AG to present promising new clinical data on lead ADC-candidate HDP-101 at ASH Annual Meeting 2024, showcasing potential for multiple myeloma treatment

Clinical Data HDP-101 Heidelberg Pharma AG ADC ASH Annual Meeting
BRIEF

published on 10/24/2024 at 11:08, 1 month 28 days ago

Heidelberg Pharma présentera ses innovations ADC en novembre 2024

Heidelberg Pharma HDP-101 Thérapie Contre Le Cancer ADC HDP-201
BRIEF

published on 10/24/2024 at 11:08, 1 month 28 days ago

Heidelberg Pharma to Showcase Its ADC Innovations in November 2024

Cancer Therapy Heidelberg Pharma HDP-101 ADCs HDP-201
PRESS RELEASE

published on 10/24/2024 at 11:03, 1 month 28 days ago

Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024
Heidelberg Pharma to present ADC candidates at scientific and financial conferences in November 2024. Updates on Amanitin-based HDP-101 and Exatecan-based HDP-201. Key targets and conference details

Heidelberg Pharma Scientific Conferences ADC Candidates Amanitin Exatecan
BRIEF

published on 10/10/2024 at 07:11, 2 months 11 days ago

Rapport intermédiaire de Heidelberg Pharma AG pour les neuf premiers mois de 2024

Rapport Financier Heidelberg Pharma Résultats Cliniques Essai Du HDP-101 Vente De Redevances
BRIEF

published on 10/10/2024 at 07:11, 2 months 11 days ago

Heidelberg Pharma AG's Interim Report for First Nine Months of 2024

Financial Report Heidelberg Pharma HDP-101 Trial Clinical Outcomes Royalty Sale
PRESS RELEASE

published on 10/10/2024 at 07:06, 2 months 11 days ago

Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
Heidelberg Pharma AG provides insights on its operational progress and financial figures for the first nine months of fiscal year 2024. Development activities, new clinical data, R&D webinars, and guidance updates are highlighted

Financial Figures Clinical Data Heidelberg Pharma AG R&D Webinars Guidance Updates
BRIEF

published on 10/01/2024 at 17:34, 2 months 19 days ago

Heidelberg Pharma Presents Promising Clinical Data for Lead ADC Candidate HDP-101

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma ADC

1 2 ... 7

Published on 12/21/2024 at 01:30, 13 hours 34 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 13 hours 34 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 14 hours 59 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 15 hours 4 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 15 hours 34 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 14 hours 13 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 14 hours 19 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 19 hours 53 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 20 hours 8 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 21 hours 4 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 2 hours 46 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 2 hours 46 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 21 hours 4 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 21 hours 4 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 21 hours 9 minutes ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News